市場調查報告書
商品編碼
1287282
輸血診斷市場 - 按產品(儀器、試劑和試劑盒),按應用(血型、疾病篩查),按最終用途(醫院、診斷實驗室、血庫)及預測,2023 - 2032年Blood Transfusion Diagnostics Market - By Product (Instruments, Reagents & Kits), By Application (Blood Grouping, Disease Screening), By End-use (Hospitals, Diagnostic Laboratories, Blood Banks) & Forecast, 2023 - 2032 |
全球輸血診斷市場規模將在2023-2032年顯著擴大。全球蓬勃發展的醫療設備行業為市場提供了成長途徑。許多已開發國家和發展中國家的政府正在對醫療設備進行大量投資,以擴大其醫療基礎設施。因此,這推動了對輸血診斷產品的需求,從而促進了市場收入。舉例來說,最近IBEF的估計表明,到2025年,印度的醫療設備市場價值可能達到500億美元。
整個輸血診斷行業根據產品、應用、最終用途和地區進行分類。
從2023年到2032年,來自儀器部分的市場佔有率將以可觀的複合年成長率成長。最近輸血儀器的進步提高了輸血過程的安全性和有效性。事實上,自動血液成分分離器和細胞挽救裝置現在可以提取特定的血液成分,減少全血輸注的需要,並將不良反應的風險降到最低。此外,接受外科手術的人顯著增加,增加了對輸血儀器的需求,如血袋、輸液泵等,推動了業務成長。
就應用而言,到2032年,輸血診斷的市場價值中來自血型的部分將大幅成長。血型鑑定的持續進步促進了該領域的成長。分子血型基因分型通過提供一種基於DNA的方法來確定血型,已經徹底改變了輸血醫學。這項技術涉及識別與血型有關的遺傳變異和特定等位基因,從而實現精確和可靠的血型鑑定。
基於終端用途,血庫部分的輸血診斷市場將在2023-2032年獲得巨大收益。世界各地的血庫數量不斷增加,為該領域的成長創造了廣闊的空間。此外,這些設施中先進設備的高度可用性使輸血更容易,進一步加強了該領域的前景。此外,對嚴格篩选和測試程序的需求不斷增加,以確保獻血的安全,這增加了對血庫的需求,從而有利於市場成長。
從2023年到2032年,亞太地區輸血診斷行業將以明顯的複合年成長率成長。不斷成長的醫療保健行業,加上該地區老年人口的增加,有利於行業的成長。根據世界衛生組織,到2040年,中國將有超過28%的人超過60歲。此外,該地區血庫數量的增加也進一步增加了對輸血診斷的需求。
Global Blood Transfusion Diagnostics Market size will expand significantly over 2023-2032. The flourishing medical device industry globally is presenting growth pathways for the market. Many governments in developed and developing countries are investing significant amounts into medical devices to expand their healthcare infrastructure. This, in consequence, has propelled the demand for blood transfusion diagnostic products, thus, contributing to market revenue. To illustrate, recent IBEF estimates suggest that the medical device market in India could be worth USD 50 billion by 2025.
The overall blood transfusion diagnostics industry is classified based on product, application, end-use, and region.
The market share from the instruments segment will grow at a considerable CAGR from 2023 to 2032. Recent advancements in blood transfusion instruments have improved the safety and efficacy of the transfusion process. In fact, automated blood component separators and cell salvage devices now allow for the extraction of specific blood components, reducing the need for whole blood transfusions and minimizing the risk of adverse reactions. Moreover, a remarkable rise in people undergoing surgical procedures has increased the need for blood transfusion instruments, such as blood bags, infusion pumps, and others, driving business growth.
In terms of application, the blood transfusion diagnostics market value from the blood grouping segment will grow substantially through 2032. Consistent advancements in blood grouping are contributing to segment growth. Molecular blood group genotyping has revolutionized transfusion medicine by providing a DNA-based method for determining blood types. This technique involves identifying genetic variations and specific alleles associated with blood groups, allowing for precise and reliable blood typing.
Based on end use, the blood transfusion diagnostics market from the blood banks segment will register huge gains over 2023-2032. Growing number of blood banks across the world is creating a broad scope for segment growth. Moreover, the high availability of advanced equipment in these facilities has made transfusion easier, further strengthening the segment outlook. Moreover, the growing need for rigorous screening and testing procedures to ensure the safety of donated blood has increased the demand for blood banks, thus, favoring market growth.
Asia Pacific blood transfusion diagnostics industry will grow at a significant CAGR from 2023 to 2032. Growing healthcare industry, coupled with the increasing geriatric population in the region, is working in favor of industry growth. As per WHO, over 28% of people in China will be over 60 years of age by 2040. Moreover, the rising number of blood banks in the region has further increased the need for blood transfusion diagnostics.